• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹腔镜两组经肛门手术超越全直肠系膜切除术治疗伴有侵犯的晚期和复发性直肠癌的益处:一项与传统腹腔镜手术方法比较的回顾性研究

Benefit of laparoscopic two-team transanal beyond total mesorectal excision for advanced and recurrent rectal cancer with invasion: a retrospective study compared with conventional laparoscopic approach.

作者信息

Shioi Ikuma, Shiraishi Takuya, Shimizu Yutaro, Uehara Kosei, Seki Takahiro, Hosoi Nobuhiro, Tateno Kouhei, Endo Mizuki, Uchida Shintaro, Yamaguchi Arisa, Katayama Chika, Shibasaki Yuta, Komine Chika, Osone Katsuya, Okada Takuhisa, Kimura Akiharu, Sano Akihiko, Sakai Makoto, Shirabe Ken, Saeki Hiroshi

机构信息

Department of General Surgical Science, Gunma University Graduate School of Medicine, 3-39-22 Showa-Machi, Maebashi, Gunma, 371-8511, Japan.

出版信息

Tech Coloproctol. 2025 May 23;29(1):120. doi: 10.1007/s10151-025-03158-8.

DOI:10.1007/s10151-025-03158-8
PMID:40410600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12102100/
Abstract

BACKGROUND

The optimal surgical approach for advanced or recurrent rectal cancer with invasion of adjacent structures remains controversial. This study aimed to clarify the feasibility of laparoscopic two-team transanal beyond total mesorectal excision in patients with advanced and recurrent rectal cancer with invasion.

METHODS

This single-center retrospective study was conducted in a single educational hospital in Japan from January 2014 to March 2024. Patients with advanced or recurrent rectal cancer who underwent laparoscopic or two-team transanal total mesorectal excision with the resection of adjacent structures were included in the analysis. Short-term outcomes were compared between the laparoscopic and transanal approaches. The burden of medical resources was assessed using a new index, Staff Time Consumed (STC = median number of participating staff members × operation time).

RESULTS

In total, 35 patients were included. More patients underwent preoperative treatment and lateral lymph-node dissection using the transanal approach. However, the operative time (539 and 339 min in the laparoscopic and transanal groups, respectively; p < 0.001) and total blood loss (274 and 70 mL, respectively; p = 0.008) were lower in the transanal group. Additionally, the positive resection margin was lower in the transanal group than in the laparoscopic group (28% and 0%, p = 0.021); STC was comparable between groups. There was no increase in postoperative mortality or morbidity. Patients with surgical difficulties had shorter operative times in the transanal group, and comparable STC.

CONCLUSIONS

Laparoscopic two-team transanal approach offers better short-term outcomes than the conventional approach in highly selected patients.

摘要

背景

对于侵犯相邻结构的晚期或复发性直肠癌,最佳手术方式仍存在争议。本研究旨在阐明腹腔镜双团队经肛门扩大全直肠系膜切除术在侵犯性晚期和复发性直肠癌患者中的可行性。

方法

本单中心回顾性研究于2014年1月至2024年3月在日本一家教学医院进行。纳入接受腹腔镜或双团队经肛门全直肠系膜切除术并切除相邻结构的晚期或复发性直肠癌患者进行分析。比较腹腔镜和经肛门手术方式的短期结局。使用一个新指标“工作人员耗时(STC = 参与工作人员中位数×手术时间)”评估医疗资源负担。

结果

共纳入35例患者。经肛门手术方式的患者更多接受了术前治疗和侧方淋巴结清扫。然而,经肛门组的手术时间(腹腔镜组和经肛门组分别为539分钟和339分钟;p < 0.001)和总失血量(分别为274毫升和70毫升;p = 0.008)更低。此外,经肛门组的切缘阳性率低于腹腔镜组(分别为28%和0%,p = 0.021);两组的STC相当。术后死亡率和发病率均未增加。手术困难的患者在经肛门组的手术时间更短,且STC相当。

结论

对于经过严格筛选的患者,腹腔镜双团队经肛门手术方式比传统手术方式具有更好的短期结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd5a/12102100/430de7fbbcc7/10151_2025_3158_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd5a/12102100/430de7fbbcc7/10151_2025_3158_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd5a/12102100/430de7fbbcc7/10151_2025_3158_Fig1_HTML.jpg

相似文献

1
Benefit of laparoscopic two-team transanal beyond total mesorectal excision for advanced and recurrent rectal cancer with invasion: a retrospective study compared with conventional laparoscopic approach.腹腔镜两组经肛门手术超越全直肠系膜切除术治疗伴有侵犯的晚期和复发性直肠癌的益处:一项与传统腹腔镜手术方法比较的回顾性研究
Tech Coloproctol. 2025 May 23;29(1):120. doi: 10.1007/s10151-025-03158-8.
2
Early Experience With Transanal Total Mesorectal Excision Compared With Laparoscopic Total Mesorectal Excision for Rectal Cancer: A Propensity Score-Matched Analysis.经肛门全直肠系膜切除术与腹腔镜全直肠系膜切除术治疗直肠癌的早期经验比较:倾向评分匹配分析。
Dis Colon Rectum. 2020 Nov;63(11):1500-1510. doi: 10.1097/DCR.0000000000001725.
3
Transanal Total Mesorectal Excision in Mid-Low Rectal Cancer: Evaluation of the Learning Curve and Comparison of Short-term Results With Standard Laparoscopic Total Mesorectal Excision.经肛门全直肠系膜切除术治疗中低位直肠癌:学习曲线评估及与标准腹腔镜全直肠系膜切除术的短期疗效比较
Dis Colon Rectum. 2021 Apr 1;64(4):380-388. doi: 10.1097/DCR.0000000000001816.
4
Two-team Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection Using Transanal Approach for Rectal Cancer: A Retrospective Study.经肛门入路行双团队全直肠系膜切除术和侧方盆腔淋巴结清扫术治疗直肠癌:一项回顾性研究。
Anticancer Res. 2023 Jul;43(7):3311-3319. doi: 10.21873/anticanres.16507.
5
Single-center comparative study of short-term outcomes of transanal and laparoscopic total mesorectal excisions for low and middle rectal cancers.经肛门与腹腔镜全直肠系膜切除术治疗中低位直肠癌的短期疗效单中心对比研究。
Surg Endosc. 2023 Jun;37(6):4698-4706. doi: 10.1007/s00464-023-09948-1. Epub 2023 Mar 8.
6
Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes.经肛门全直肠系膜切除术(TaTME)与 MRI 定义低位直肠癌的腹腔镜 TME 比较:基于倾向评分匹配的肿瘤学结局分析。
Surg Endosc. 2019 Aug;33(8):2459-2467. doi: 10.1007/s00464-018-6530-4. Epub 2018 Oct 22.
7
An international multicentre prospective audit of elective rectal cancer surgery; operative approach versus outcome, including transanal total mesorectal excision (TaTME).国际多中心前瞻性直肠癌手术审计;手术方法与结果,包括经肛门全直肠系膜切除术(TaTME)。
Colorectal Dis. 2018 Sep;20 Suppl 6:33-46. doi: 10.1111/codi.14376.
8
[Safety and prognosis analysis of transanal total mesorectal excision versus laparoscopic mesorectal excision for mid-low rectal cancer].经肛门全直肠系膜切除术与腹腔镜直肠系膜切除术治疗中低位直肠癌的安全性及预后分析
Zhonghua Wei Chang Wai Ke Za Zhi. 2022 Jun 25;25(6):522-530. doi: 10.3760/cma.j.cn441530-20210811-00321.
9
Outcomes of a Single Surgeon-Based Transanal-Total Mesorectal Excision (TATME) for Rectal Cancer.基于单外科医生的经肛门全直肠系膜切除术(TATME)治疗直肠癌的疗效
J Gastrointest Cancer. 2018 Dec;49(4):455-462. doi: 10.1007/s12029-017-9989-7.
10
Transanal down-to-up dissection of the distal rectum as a viable approach to achieve total mesorectal excision in laparoscopic sphincter-preserving surgery for rectal cancer near the anus: a study of short- and long-term outcomes of 123 consecutive patients from a single Japanese institution.经肛门由下至上游离远端直肠以实现肛门附近直肠癌腹腔镜保肛手术中全直肠系膜切除术:来自日本单中心的 123 例连续患者的短期和长期结果研究。
World J Surg Oncol. 2022 Nov 15;20(1):363. doi: 10.1186/s12957-022-02826-5.

引用本文的文献

1
Comparison of the postoperative outcomes between the robotic transabdominal approach alone and the combined robotic transabdominal and conventional transanal approach for rectal cancer.单纯机器人经腹入路与机器人经腹联合传统经肛门入路治疗直肠癌的术后结果比较。
Surg Today. 2025 Aug 23. doi: 10.1007/s00595-025-03120-z.

本文引用的文献

1
A systematic review and meta-analysis of oncological outcomes with transanal total mesorectal excision for rectal cancer.直肠癌经肛全直肠系膜切除术的肿瘤学结局的系统评价和荟萃分析。
Colorectal Dis. 2024 May;26(5):837-850. doi: 10.1111/codi.16982. Epub 2024 Apr 8.
2
Comparing robotic with laparoscopic beyond total mesorectal excision for advanced rectal cancer-a propensity-matched analysis.比较机器人辅助与腹腔镜辅助超全直肠系膜切除术治疗中晚期直肠癌的倾向评分匹配分析。
Colorectal Dis. 2024 Mar;26(3):449-458. doi: 10.1111/codi.16866. Epub 2024 Jan 18.
3
Long-term oncological outcomes of transanal versus laparoscopic total mesorectal excision for mid-low rectal cancer: a retrospective analysis of 2502 patients.
经肛门与腹腔镜全直肠系膜切除术治疗中低位直肠癌的长期肿瘤学结局:2502 例患者的回顾性分析。
Int J Surg. 2024 Mar 1;110(3):1611-1619. doi: 10.1097/JS9.0000000000000992.
4
Two-team Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection Using Transanal Approach for Rectal Cancer: A Retrospective Study.经肛门入路行双团队全直肠系膜切除术和侧方盆腔淋巴结清扫术治疗直肠癌:一项回顾性研究。
Anticancer Res. 2023 Jul;43(7):3311-3319. doi: 10.21873/anticanres.16507.
5
Outcomes of extended total mesorectal excision in patients with locally advanced rectal cancer.局部进展期直肠癌患者行扩大全直肠系膜切除术的疗效。
Colorectal Dis. 2023 Jul;25(7):1423-1432. doi: 10.1111/codi.16606. Epub 2023 May 28.
6
Annual report on National Clinical Database 2020 for gastroenterological surgery in Japan.日本2020年胃肠外科全国临床数据库年度报告。
Ann Gastroenterol Surg. 2023 Feb 9;7(3):367-406. doi: 10.1002/ags3.12662. eCollection 2023 May.
7
Outcomes of open vs laparoscopic vs robotic vs transanal total mesorectal excision (TME) for rectal cancer: a network meta-analysis.直肠癌开放手术、腹腔镜手术、机器人手术与经肛门全直肠系膜切除术(TME)的疗效:一项网状Meta分析。
Tech Coloproctol. 2023 May;27(5):345-360. doi: 10.1007/s10151-022-02739-1. Epub 2022 Dec 12.
8
Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer (Ta-LaTME study): multicentre, randomized, open-label trial.经肛门全直肠系膜切除术与腹腔镜全直肠系膜切除术治疗中低位直肠癌(Ta-LaTME 研究):多中心、随机、开放标签试验。
Br J Surg. 2023 Jan 10;110(2):150-158. doi: 10.1093/bjs/znac324.
9
Morbidity, Mortality, and Pathologic Outcomes of Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer Short-term Outcomes From a Multicenter Randomized Controlled Trial.经肛门与腹腔镜全直肠系膜切除术治疗直肠癌的短期结局:多中心随机对照试验的发病率、死亡率和病理结局。
Ann Surg. 2023 Jan 1;277(1):1-6. doi: 10.1097/SLA.0000000000005523. Epub 2022 Jul 11.
10
The learning curve of transanal total mesorectal excision for rectal cancer is associated with local recurrence: results from a multicentre external audit.经肛门全直肠系膜切除术治疗直肠癌的学习曲线与局部复发相关:来自多中心外部审核的结果。
Colorectal Dis. 2021 Aug;23(8):2020-2029. doi: 10.1111/codi.15722. Epub 2021 Jun 9.